Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Reinvestment Rate
Chengdu Kanghong Pharmaceuticals Group Co Ltd cash flow reinvestment rate. Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥105.16 Million (capex CN¥105.16 Million ) from operating cash flow of CN¥504.02 Million. Explore Chengdu Kanghong Pharmaceuticals Group C cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Cash flow reinvestment rate of Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025. Historical reinvestment intensity for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. Explore Chengdu Kanghong Pharmaceuticals Group C capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Chengdu Kanghong Pharmaceuticals Group Co Ltd Cash Flow Reinvestment Rate by Year (2009–2025)
Chengdu Kanghong Pharmaceuticals Group Co Ltd cash flow reinvestment rate by year from 2009 to 2025. Year-by-year capital reinvestment analysis for Chengdu Kanghong Pharmaceuticals Group Co Ltd. For the full cash flow conversion analysis, see Chengdu Kanghong Pharmaceuticals Group C (002773) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.20x | CN¥299.36 Million | CN¥1.50 Billion | CN¥262.48 Million | ▲ +35.7% |
| 2024 | 0.15x | CN¥207.10 Million | CN¥1.41 Billion | CN¥159.39 Million | ▲ +22.8% |
| 2023 | 0.12x | CN¥145.49 Million | CN¥1.22 Billion | CN¥138.87 Million | ▼ -80.6% |
| 2022 | 0.62x | CN¥570.76 Million | CN¥925.15 Million | CN¥355.21 Million | ▼ -62.9% |
| 2021 | 1.66x | CN¥821.27 Million | CN¥494.11 Million | CN¥569.42 Million | ▼ -27.6% |
| 2020 | 2.29x | CN¥627.07 Million | CN¥273.32 Million | CN¥617.07 Million | ▲ +66.5% |
| 2019 | 1.38x | CN¥1.12 Billion | CN¥812.15 Million | CN¥962.88 Million | ▼ -28.9% |
| 2018 | 1.94x | CN¥680.45 Million | CN¥350.88 Million | CN¥458.45 Million | ▲ +159.6% |
| 2017 | 0.75x | CN¥572.88 Million | CN¥766.86 Million | CN¥312.88 Million | ▲ +50.4% |
| 2016 | 0.50x | CN¥420.39 Million | CN¥846.35 Million | CN¥170.23 Million | ▼ -16.9% |
| 2015 | 0.60x | CN¥288.04 Million | CN¥481.97 Million | CN¥115.83 Million | ▲ +92.9% |
| 2014 | 0.31x | CN¥90.27 Million | CN¥291.38 Million | CN¥90.27 Million | ▲ +33.8% |
| 2013 | 0.23x | CN¥77.16 Million | CN¥333.31 Million | CN¥77.16 Million | ▼ -49.6% |
| 2012 | 0.46x | CN¥129.51 Million | CN¥281.84 Million | CN¥129.51 Million | ▼ -50.7% |
| 2011 | 0.93x | CN¥157.25 Million | CN¥168.86 Million | CN¥157.25 Million | ▼ -3.3% |
| 2010 | 0.96x | CN¥131.76 Million | CN¥136.79 Million | CN¥131.76 Million | ▼ -34.0% |
| 2009 | 1.46x | CN¥158.27 Million | CN¥108.42 Million | CN¥158.27 Million | — |